Article,

A selective bi-site immunoenzymatic procedure for human Lpa lipoprotein quantification using monoclonal antibodies against apoa and apoB.

, , , , , and .
Journal of Lipid Research, 30 (9): 1437--1443 (September 1989)

Abstract

A selective bi-site ELISA assay procedure for quantification of Lpa lipoprotein in human plasma based on linkage of apoa to apoB is described. The lipoproteins referred to as apoa:B were captured by a mixture of two anti-apoa monoclonal antibodies (K07, K09) and were revealed by a mixture of six anti-apoB monoclonal antibodies coupled to peroxidase. Since apoa and plasminogen have striking similarities in protein structure, the selective binding of Lpa:B in our assay depended upon the marked difference in affinity of the K07 and K09 mixture for Lpa:B (Kd = 0.32 x 10(-10) M) versus plasminogen (Kd = 0.47 x 10(-7)M). The high sensitivity (the Lpa:B working range 0.06-0.40 micrograms/ml) and the use of anti-apoB as antibody tracer added to the selectivity of the assay. The expression of K07 and K09 epitopes determined by competitive inhibition method and the reactivity of Lpa:B particles measured by bi-site ELISA were similar on individual lipoproteins, independent to their plasma levels. The assay is precise, and intra- and interassay coefficients of variation were 4.7% and 9.6%, respectively. It yields quantitative Lpa:B values that correlate highly with Lpa levels obtained by electroimmunoassay with polyclonal antibody (r = 0.73) or with Lpa levels measured by the other bi-site ELISA using only K07 and K09 antibodies (r = 0.96). However, upon analyzing each individual plasma with an arbitrary Lpa-cut off of 15 mg/dl, evidence of the qualitative aspect of the lipoprotein was obtained. The group with Lpa less than 15 mg/dl had higher frequency of subjects (65%) with the ratio Lpa/Lpa:B above 1.5.(ABSTRACT TRUNCATED AT 250 WORDS)

Tags

Users

  • @biblio24

Comments and Reviews